{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:39:15Z","timestamp":1794011955311,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00234-025-03888-4","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:53:21Z","timestamp":1768290801000},"page":"673-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting recurrence in silent corticotroph adenomas: a habitat analysis and comprehensive nomogram approach"],"prefix":"10.1007","volume":"68","author":[{"given":"Xuening","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"lingxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"mengyuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"3888_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.04.002","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. https:\/\/doi.org\/10.1016\/j.ecl.2020.04.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3888_CR2","doi-asserted-by":"publisher","unstructured":"Banskota S, Adamson DC (2021) Pituitary Adenomas: From Diagnosis to Therapeutics. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines90504943","DOI":"10.3390\/biomedicines90504943"},{"key":"3888_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19699","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA. https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"key":"3888_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08361-3","author":"W Rui","year":"2022","unstructured":"Rui W, Qiao N, Wu Y et al (2022) Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-021-08361-3","journal-title":"Eur Radiol"},{"key":"3888_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1769-8","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 world health organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-017-1769-8","journal-title":"Acta Neuropathol"},{"key":"3888_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09703-7","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A et al (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"3888_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03673.x","author":"HY Cho","year":"2010","unstructured":"Cho HY, Cho SW, Kim SW et al (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03673.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3888_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0624-39","author":"O Cooper","year":"2015","unstructured":"Cooper O (2015) Silent corticotroph adenomas. Pituitary. https:\/\/doi.org\/10.1007\/s11102-014-0624-39","journal-title":"Pituitary"},{"key":"3888_CR9","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000429858.96652.1e","author":"A Jahangiri","year":"2013","unstructured":"Jahangiri A, Wagner JR, Pekmezci M et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery. https:\/\/doi.org\/10.1227\/01.neu.0000429858.96652.1e","journal-title":"Neurosurgery"},{"key":"3888_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01133-8","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhu J, Feng M et al (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary. https:\/\/doi.org\/10.1007\/s11102-021-01133-8","journal-title":"Pituitary"},{"key":"3888_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0844-4","author":"F Langlois","year":"2018","unstructured":"Langlois F, Lim DST, Yedinak CG et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary. https:\/\/doi.org\/10.1007\/s11102-017-0844-4","journal-title":"Pituitary"},{"key":"3888_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03449-w","author":"HG Vuong","year":"2023","unstructured":"Vuong HG, Dunn IF (2023) The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis. Endocrine. https:\/\/doi.org\/10.1007\/s12020-023-03449-w","journal-title":"Endocrine"},{"key":"3888_CR13","doi-asserted-by":"publisher","DOI":"10.3171\/2020.10.JNS203236","author":"BA Strickland","year":"2021","unstructured":"Strickland BA, Shahrestani S, Briggs RG et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg. https:\/\/doi.org\/10.3171\/2020.10.JNS203236","journal-title":"J Neurosurg"},{"key":"3888_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03673.x","author":"HY Cho","year":"2010","unstructured":"Cho HY, Cho SW, Kim SW, Shin CS, Park KS, Kim SY (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03673.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3888_CR15","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02326","author":"W Saeger","year":"2007","unstructured":"Saeger W, L\u00fcdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje.1.02326","journal-title":"Eur J Endocrinol"},{"key":"3888_CR16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017170845","author":"J Juan-Albarrac\u00edn","year":"2018","unstructured":"Juan-Albarrac\u00edn J, Fuster-Garcia E, P\u00e9rez-Girb\u00e9s A et al (2018) Glioblastoma: vascular habitats detected at preoperative dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging predict survival. Radiology. https:\/\/doi.org\/10.1148\/radiol.2017170845","journal-title":"Radiology"},{"key":"3888_CR17","doi-asserted-by":"publisher","unstructured":"Gillies RJ, Balagurunathan Y (2018) Perfusion MR imaging of breast cancer: insights using habitat imaging. Radiology. https:\/\/doi.org\/10.1148\/radiol.201818027119","DOI":"10.1148\/radiol.201818027119"},{"key":"3888_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-06057-y","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang W, Liang X et al (2025) Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-024-06057-y","journal-title":"J Transl Med"},{"key":"3888_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03724-3","author":"W Caii","year":"2024","unstructured":"Caii W, Wu X, Guo K, Chen Y, Shi Y, Chen J (2024) Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients. Cancer Immunol Immunother. https:\/\/doi.org\/10.1007\/s00262-024-03724-3","journal-title":"Cancer Immunol Immunother"},{"key":"3888_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05897-y","author":"J Gong","year":"2024","unstructured":"Gong J, Lu J, Zhang W et al (2024) A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-024-05897-y","journal-title":"J Transl Med"},{"key":"3888_CR21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2556","author":"N Beig","year":"2020","unstructured":"Beig N, Bera K, Prasanna P et al (2020) Radiogenomic-based survival risk stratification of tumor habitat on Gd-T1w MRI is associated with biological processes in glioblastoma. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2556","journal-title":"Clin Cancer Res"},{"key":"3888_CR22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.230037","author":"J Wu","year":"2020","unstructured":"Wu J, Gensheimer MF, Zhang N et al (2020) Tumor subregion evolution-based imaging features to assess early response and predict prognosis in oropharyngeal cancer. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.119.230037","journal-title":"J Nucl Med"},{"key":"3888_CR23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0749","author":"S Asioli","year":"2019","unstructured":"Asioli S, Righi A, Iommi M et al (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-18-0749","journal-title":"Eur J Endocrinol"},{"key":"3888_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.2020190168","author":"R Verma","year":"2020","unstructured":"Verma R, Correa R, Hill VB et al (2020) Tumor habitat-derived radiomic features at pretreatment MRI that are prognostic for progression-free survival in glioblastoma are associated with key morphologic attributes at histopathologic examination: a feasibility study. Radiology: Artificial Intelligence. https:\/\/doi.org\/10.1148\/ryai.2020190168","journal-title":"Radiology: Artificial Intelligence"},{"key":"3888_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-023-01695-6","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang C, Sheng R, Dai Y, Zeng M (2023) Predicting the recurrence of hepatocellular carcinoma (\u2264 5 cm) after resection surgery with promising risk factors: habitat fraction of tumor and its peritumoral micro-environment. Radiol Med. https:\/\/doi.org\/10.1007\/s11547-023-01695-6","journal-title":"Radiol Med"},{"key":"3888_CR26","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003142","author":"W He","year":"2025","unstructured":"He W, Yao S, Yu Y et al (2025) Treatment strategies and long-term outcomes in silent corticotroph adenomas: a single-center retrospective study of 367 cases. Neurosurgery. https:\/\/doi.org\/10.1227\/neu.0000000000003142","journal-title":"Neurosurgery"},{"issue":"3","key":"3888_CR27","first-page":"347","volume":"29","author":"M Pawlikowski","year":"2008","unstructured":"Pawlikowski M, Kunert-Radek J, Radek M (2008) Silent\"corticotropinoma. Neuro Endocrinol Lett 29(3):347\u2013350","journal-title":"Neuro Endocrinol Lett"},{"key":"3888_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0864-8","author":"A Ben-Shlomo","year":"2018","unstructured":"Ben-Shlomo A, Cooper O (2018) Silent corticotroph adenomas. Pituitary. https:\/\/doi.org\/10.1007\/s11102-018-0864-8","journal-title":"Pituitary"},{"key":"3888_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.07.013","author":"Z Xu","year":"2014","unstructured":"Xu Z, Ellis S, Lee CC et al (2014) Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3888_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13365","author":"AK Watts","year":"2017","unstructured":"Watts AK, Easwaran A, McNeill P, Wang YY, Inder WJ, Caputo C (2017) Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: results from a single Australian centre. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.13365","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-025-03888-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-025-03888-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-025-03888-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:52:49Z","timestamp":1776750769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-025-03888-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3888"],"URL":"https:\/\/doi.org\/10.1007\/s00234-025-03888-4","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of our institution, and conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent for participation was obtained from all patients or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}